TLGT = Market Cap $70 Million / 69 Drugs on Market in USA & Canada / 22 Drugs awaiting FDA approval / Additional 39 Products in Pipeline / Profitability expected this year / Strong Insider & Institutional Ownership (see below) = Cheapest Pharma play out there with significant upside potential ..Fair value is between $6-8 right NOW .GL Teligent (TLGT) Market Cap: $70 Million Price: $1.31 Shares Out: 53.7 Million We currently have 22 Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of approximately $1.6 billion (IQVIA, June 2018). Institutional Ownership: Signet Healthcare Partners LLC 9,851,861 venBio Select Advisor LLC 5,299,431 Elk Creek Partners LLC 4,602,755 BlackRock Fund Advisors 3,257,509 Prosight Management LP 3,240,761 Broadfin Capital LLC 3,052,852 AMI Asset Management Corp. 2,714,292 The Vanguard Group, Inc. 2,165,610 Eversept Partners LP 2,112,098 Sanders Morris Harris LLC (Investment Management) 1,545,032
stock is massive oversold and heavily shorted with over 20% of the O/S so any good news will let this low float stock exploding to the upside .
Good News ..and there is 21 more Drugs awaiting FDA approval and 39 Drugs in Pipeline moving closer to FDA filing Teligent, Inc. Announces FDA Approval of Desonide Ointment, 0.05% https://www.globenewswire.com/news-...s-FDA-Approval-of-Desonide-Ointment-0-05.html
